PEStore

Fund of Funds

Ceros Capital Markets

Ceros Capital Markets invests in other funds rather than directly in companies, from United States. It states a focus on healthcare & life sciences.

Disclosed holdings16
Earliest stated investment1999
HeadquartersUnited States
Largest single fundNot stated

Stated investment criteria

What Ceros Capital Markets says it buys

Read from Ceros Capital Markets’s own website in August 2026. This is what the firm says it buys, not what anyone has recorded it buying, and figures are shown in the currency the firm itself used - nothing here is converted. Every line links to the page it was read from.

OfficesMiami, Tel Aviv, Dallas, Shanghai, Tokyo2
People listed on its team page51

A stated mandate is a firm’s description of itself and was true of the page on the day it was read; firms widen and narrow what they will look at without updating the site. The team figure counts the people the firm shows on one team page, so it is a floor rather than a headcount: firms that split their team across tabs or load it in pages will read low. Nothing here is a commitment by Ceros Capital Markets to consider any particular business, and nothing on this page is represented as being for sale.

Portfolio

Disclosed holdings

Companies Ceros Capital Markets lists on its own website. 7 carry a stated investment year.

CompanyInvestedYears heldRecorded transaction
Insightec199927
OrthoSensor200620
DermaSensor200917
PathologyWatch201214
Aquyre Biosciences201313
Cordio Medical201313
Momentis Surgical201313
Accuryn
Aquyre
Broker Check
CRS
Member SIPC
Wesper
cordio-med.com
triflocv.com
trisaluslifesci.com

Compiled from Ceros Capital Markets’s published portfolio page. Where a recorded transaction is shown, that company was the target of a reported deal and has most likely already been realised. Nothing here is represented as being for sale.

Valuation context

Transaction values in Healthcare & Life Sciences

What companies have actually sold for in healthcare & life sciences, across 1,263 recorded transactions.

Median consideration$110m
Middle 50%$30m-$318m
Revenue multiple2.8×
EBITDA multiple12.5×

The full healthcare & life sciences picture - most active acquirers, recent transactions and every investor in the sector.

For owners

Own a healthcare & life sciences business?

The investors on this page acquire companies like yours. A confidential valuation costs nothing, commits you to nothing, and nobody is told you asked.

Request a confidential valuation

For investors

Is this Ceros Capital Markets?

Claim this profile to correct anything wrong and tell us what you are looking for. We will send matching opportunities as they arise.

Claim or correct this profile

Targeted buyer search

Which hundred of these would actually buy your business?

A researched shortlist with a verified deal-team contact for each, and the reason it is on the list. Fixed fee, from $1,450 - or we make the approach for you and hand you the conversations.

See how it works

Comparable investors

Similar mandates

Other fund of funds investors active in healthcare & life sciences.